Company
Praxis
advancing our portfolio of precision therapies for central nervous system disorders
Also known as Praxis Precision Medicines, Praxis Precision Medicines Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Cambridge, MA, United States
- Legal name
- Praxis Precision Medicines Inc.
- praxismedicines.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Praxis Precision Medicines is a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance.
Funding snapshot
- Total raised
- $31.9MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $10M2019-06-18
Funding rounds
- Round, 2019
- $10M2019-06-18, SEC form D sold, 5 investors
- Round, 2018
- $18.8M2018-03-13, SEC form D sold, 6 investors
- Round, 2016
- $3.1M2016-10-31, SEC form D sold, 2 investors
Loading relationship preview